Skip to Content

Flucelvax Approval History

FDA Approved: Yes (First approved November 20, 2012)
Brand name: Flucelvax
Generic name: influenza virus vaccine
Company: Novartis
Treatment for: Influenza Prophylaxis

Flucelvax (influenza virus vaccine) is an inactivated vaccine indicated for active immunization for the prevention of influenza.

Development History and FDA Approval Process for Flucelvax

DateArticle
Nov 21, 2012Approval FDA Approves Flucelvax - First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide